NCT03344744

Brief Summary

The investigators aim to investigate and understand the circulating miRNA profiles after acute aneurysmal subarachnoid haemorrhage and underlying pathological significance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 12, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 17, 2017

Completed
13 days until next milestone

Study Start

First participant enrolled

November 30, 2017

Completed
5.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2023

Completed
Last Updated

September 7, 2023

Status Verified

September 1, 2023

Enrollment Period

5.8 years

First QC Date

October 12, 2017

Last Update Submit

September 6, 2023

Conditions

Keywords

Subarachnoid Haemorrhage

Outcome Measures

Primary Outcomes (1)

  • Circulating micro RNA concentrations

    Serum micro RNA concentrations

    Day 3

Secondary Outcomes (3)

  • Circulating micro RNA change

    Days 1,2,3,7

  • Cerebrospinal fluid micro RNA concentrations

    Day 1,2,3,7

  • Cerebrospinal fluid micro RNA change

    Days 1,2,3,7

Study Arms (3)

SAH with DCI

Aneurysmal subarachnoid haemorrhage patients with delayed cerebral infarction

SAH nonDCI

Aneurysmal subarachnoid haemorrhage patients without delayed cerebral infarction

Control

Healthy volunteers

Eligibility Criteria

Age21 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

* Acute aneurysmal subarachnoid hemorrhage patients with and without delayed cerebral infarction * Healthy volunteers

You may qualify if:

  • Aneurysmal subarachnoid hemorrhage patients within the first 72 hours or Healthy volunteers

You may not qualify if:

  • Previous neurological diseases such as stroke or dementia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Surgery, The Chinese University of Hong Kong

Hong Kong, China

Location

Related Publications (3)

  • Lu G, Wong MS, Xiong MZQ, Leung CK, Su XW, Zhou JY, Poon WS, Zheng VZY, Chan WY, Wong GKC. Circulating MicroRNAs in Delayed Cerebral Infarction After Aneurysmal Subarachnoid Hemorrhage. J Am Heart Assoc. 2017 Apr 25;6(4):e005363. doi: 10.1161/JAHA.116.005363.

    PMID: 28442458BACKGROUND
  • Su XW, Chan AH, Lu G, Lin M, Sze J, Zhou JY, Poon WS, Liu Q, Zheng VZ, Wong GK. Circulating microRNA 132-3p and 324-3p Profiles in Patients after Acute Aneurysmal Subarachnoid Hemorrhage. PLoS One. 2015 Dec 16;10(12):e0144724. doi: 10.1371/journal.pone.0144724. eCollection 2015.

    PMID: 26675167BACKGROUND
  • Wong GK, Lam S, Ngai K, Wong A, Mok V, Poon WS; Cognitive Dysfunction after Aneurysmal Subarachnoid Haemorrhage Investigators. Evaluation of cognitive impairment by the Montreal cognitive assessment in patients with aneurysmal subarachnoid haemorrhage: prevalence, risk factors and correlations with 3 month outcomes. J Neurol Neurosurg Psychiatry. 2012 Nov;83(11):1112-7. doi: 10.1136/jnnp-2012-302217. Epub 2012 Jul 31.

    PMID: 22851612BACKGROUND

Biospecimen

Retention: SAMPLES WITHOUT DNA

Serum

MeSH Terms

Conditions

Subarachnoid Hemorrhage

Condition Hierarchy (Ancestors)

Intracranial HemorrhagesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • George KC Wong

    Chinese University of Hong Kong

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor(Clinical)

Study Record Dates

First Submitted

October 12, 2017

First Posted

November 17, 2017

Study Start

November 30, 2017

Primary Completion

August 31, 2023

Study Completion

August 31, 2023

Last Updated

September 7, 2023

Record last verified: 2023-09

Locations